Msos stock forecast 2025 based on current market trends

Based on current market trends, the "MSOS stock forecast 2025" indicates potential upside if U.S. cannabis reform accelerates. Institutional money could flow in, lifting average trading volumes by over 30%, with projected price targets ranging from $12 to $18 per share under moderate growth scenarios. Until restrictions are eased, “pot stocks,” like these seven cannabis stocks to sell, are likely to remain under pressure. Especially as fiscal results continue to disappoint, and high cash burn necessitates dilutive capital raising. Jazz Pharmaceuticals' cannabis business stems from its 2021 acquisition of GW Pharmaceuticals and its epilepsy medicine Epidiolex for a whopping US$7.2 billion. This made big waves as it was one of the largest moves by a traditional pharmaceutical company into the cannabis space. Short-term headwinds like tight credit markets may cap rallies, but the "MSOS stock forecast 2025" leans bullish if the SAFE Banking Act passes. A liquidity bump could re-rate the sector’s P/E ratios from 9x to 15x on consensus earnings.